Skip to main content
Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.800
+0.060 (2.19%)
At close: Feb 27, 2026, 4:00 PM EST
2.790
-0.010 (-0.36%)
After-hours: Feb 27, 2026, 6:24 PM EST

Immutep Revenue

Immutep had revenue of 6.03M AUD in the half year ending December 31, 2025, with 185.52% growth. This brings the company's revenue in the last twelve months to 7.92M, up 62.39% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 5.04M with 31.28% growth.

Revenue (ttm)
7.92M AUD
Revenue Growth
+62.39%
P/S Ratio
76.49
Revenue / Employee
255,572 AUD
Employees
31
Market Cap
404.21M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20255.04M1.20M31.28%
Jun 30, 20243.84M336.16K9.59%
Jun 30, 20233.51M-1.21M-25.64%
Jun 30, 20224.71M851.56K22.04%
Jun 30, 20213.86M-9.88M-71.88%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 161.32M
Niagen Bioscience 124.71M
Enanta Pharmaceuticals 66.98M
LENZ Therapeutics 17.50M
Verastem 13.38M
PureTech Health 6.39M
Absci 2.82M
Upstream Bio 2.80M
Revenue Rankings

IMMP News

More News